According to Sanbo Neurology's announcement, TBP 3Doctors Limited, a shareholder holding 5% or more of the company's shares, reduced its holdings by 1.398 million shares through centralized bidding transactions from June 30, 2026 to September 3, 2026, accounting for 0.68% of the company's total share capital. After this change in equity, the shareholder held 288.07.25 million shares of the company, accounting for 13.99% of the company's total share capital, and the equity change ratio reached an integer multiple of 1%. The current holdings reduction is in line with the previously disclosed holdings reduction plan. Currently, the holdings reduction plan has not been implemented, and will not lead to a change in the company's control.

According to Sanbo Neurology's announcement, TBP 3Doctors Limited, a shareholder holding 5% or more of the company's shares, reduced its holdings by 1.398 million shares through centralized bidding transactions from June 30, 2026 to September 3, 2026, accounting for 0.68% of the company's total share capital. After this change in equity, the shareholder held 288.07.25 million shares of the company, accounting for 13.99% of the company's total share capital, and the equity change ratio reached an integer multiple of 1%. The current holdings reduction is in line with the previously disclosed holdings reduction plan. Currently, the holdings reduction plan has not been implemented, and will not lead to a change in the company's control.